Table V.
Effective doses (ED) of 131I as label in mSv/MBq for beta, photon, total and ED.
| Target organ | Beta | Photon | Total | ED Cont. |
|---|---|---|---|---|
| Adrenals | 3.01E-02 | 5.77E-02 | 8.78E-02 | 2.19E-04 |
| Brain | 7.20E-03 | 1.63E-02 | 2.35E-02 | 5.88E-05 |
| Breasts | 3.01E-02 | 3.18E-02 | 6.19E-02 | 3.10E-03 |
| Lower large intestinal wall | 7.33E-02 | 4.95E-02 | 1.23E-01 | 1.47E-02 |
| Small intestine | 6.36E-02 | 5.30E-02 | 1.17E-01 | 2.91E-04 |
| Stomach wall | 3.01E-02 | 5.10E-02 | 8.11E-02 | 9.73E-03 |
| Upper large intestinal wall | 5.67E-02 | 5.18E-02 | 1.09E-01 | 2.71E-04 |
| Kidneys | 1.48E-01 | 6.23E-02 | 2.11E-01 | 5.27E-04 |
| Liver | 1.21E-01 | 6.94E-02 | 1.90E-01 | 9.52E-03 |
| Lungs | 1.42E-01 | 5.18E-02 | 1.94E-01 | 2.33E-02 |
| Muscle | 3.69E-02 | 3.68E-02 | 7.37E-02 | 1.84E-04 |
| Ovaries | 3.01E-02 | 5.11E-02 | 8.12E-02 | 1.62E-02 |
| Pancreas | 3.01E-02 | 6.17E-02 | 9.18E-02 | 2.30E-04 |
| Red marrow | 2.16E-02 | 4.30E-02 | 6.46E-02 | 7.75E-03 |
| Osteogenic cells | 7.70E-02 | 5.09E-02 | 1.28E-01 | 1.28E-03 |
| Skin | 3.01E-02 | 2.34E-02 | 5.35E-02 | 5.35E-04 |
| Spleen | 2.06E-01 | 7.16E-02 | 2.78E-01 | 6.94E-03 |
| Thymus | 3.01E-02 | 4.83E-02 | 7.84E-02 | 1.96E-04 |
| Urinary bladder wall | 5.77E-02 | 4.61E-02 | 1.04E-01 | 5.19E-03 |
| Uterus | 3.01E-02 | 5.15E-02 | 8.17E-02 | 2.04E-04 |